Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mejean

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 16, 2022
Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy SettingL Mauge, L Phan, N Benhamouda, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 9, 2008
The use of partial nephrectomy in European tertiary care centersL Zini, J J Patard, U Capitanio, et al.
International Urology and Nephrology|April 13, 2019
Long-term oncological outcomes of cystic renal cell carcinoma according to the Bosniak classificationR Boissier, I Ouzaid, F X Nouhaud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]B Peyronnet, C Vaessen, Y Grassano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative GroupJ M Tourani, C Pfister, J F Berdah, et al.
World Journal of Urology|November 7, 2014
The accuracy of renal tumor biopsy: analysis from a national prospective studyJ C Bernhard, P Bigot, G Pignot, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 16, 2022
Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy SettingL Mauge, L Phan, N Benhamouda, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 9, 2008
The use of partial nephrectomy in European tertiary care centersL Zini, J J Patard, U Capitanio, et al.
International Urology and Nephrology|April 13, 2019
Long-term oncological outcomes of cystic renal cell carcinoma according to the Bosniak classificationR Boissier, I Ouzaid, F X Nouhaud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]B Peyronnet, C Vaessen, Y Grassano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative GroupJ M Tourani, C Pfister, J F Berdah, et al.
World Journal of Urology|November 7, 2014
The accuracy of renal tumor biopsy: analysis from a national prospective studyJ C Bernhard, P Bigot, G Pignot, et al.
Pageof 7